Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene

Combining virus-enhanced immunogenicity with direct delivery of immunomodulatory molecules would represent a novel treatment modality for melanoma, and would require development of new viral vectors capable of targeting melanoma cells preferentially. Here we explore the use of rodent protoparvovirus...

Full description

Bibliographic Details
Main Authors: Matthew Marr, Anthony D’Abramo, Nikea Pittman, Mavis Agbandje-McKenna, Susan F. Cotmore, Peter Tattersall
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/10/2/54